Kimmel, G.L., Smith, K., Kochhar, D.M. and Pratt, R.M. (1982) Proceedings of the consensus workshop on in vitro teratogenesis testing. Teratog. Carcinog. Mutagen., 2, i–v.
Fantel, A.G. (1982) Culture of whole rodent embryos in teratogen screening. Teratog. Carcinog. Mutagen., 2, 231–242.
Jelinek, R. (1982) Use of chick embryo in screening for embryotoxicity. Teratog. Carcinog. Mutagen., 2, 255–261.
Johnson, E.M., Gorman, R.M., Gabel, B.E.G. and George, M.E. (1982) The hydra aftenuata system for detection of teratogenic hazards. Teratog. Carcinog. Mutagen., 2, 263–276.
Best, J.B. and Morita, M. (1982) Planarians as a model system for in vitro teratogenesis studies. Teratog. Carcinog. Mutagen., 2, 277–291.
Schuler, R.L., Hardin, B.D. and Nierneier, R.W. (1982) Drosophila as a tool for the rapid assessment of chemicals for teratogenicity. Teratog. Carcinog. Mutagen., 2, 293–301.
Keller, S.J. and Smith, M.K. (1982) Animal virus screens for potential teratogens. I. Poxvirus morphogenesis. Teratog. Carcinog. Mutagen., 2, 361–374.
Kochhar, D.M. (1982) Embryonic limb bud organ culture in assessment of teratogenicity of environmental agents. Teratog. Carcinog. Mutagen., 2, 303–312.
Pratt, R.M., Grove, R.I. and Willis, W.D. (1982) Prescreening for environmental teratogens using cultured mesenchymal cells from the humanembryonic palate. Teratog. Carcinog. Mutagen., 2, 313–318.
Greenberg, J.H. (1982) Detection of teratogens by differentiating embryonic neural crest cells in culture: Evaluation as a screening system. Teratog. Carcinog. Mutagen., 2, 319–323.
Braun, A.G., Nichinson, B.B. and Horowicz, P.B. (1982) Inhibition of tumor cell attachment to concanavalin A-coated surface as an assay for teratogenic agents: approaches to validation. Teratog. Carcinog. Mutagen., 2, 343–354.
Wilson, J.G. (1978) Review of in vitro systems with potential for use in teratogenicity screening. J. Environ. Pathol. Toxicol., 2, 149–167.
Braun, A.G., Emerson, D.J. and Nichinson, B.B. (1979) Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfaces. Nature, 282, 507–509.
Braun, A.G., Buckner, C.A., Emerson, D.J. and Nichinson, B.B. (1982) Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents. Proc. Natl. Acad. Sci. U.S.A., 79, 2056–2060.
Spielmann, H., Seiler, A., Bremer, S., Hareng, L., Hartung, T., Ahr, H., Faustman, E., Haas, U., Moffat, G.J., Nau, H., Vanparys, P., Piersma, A., Sintes, J.R. and Stuart, J. (2006) The practical application of three validated in vitro embryotoxicity tests. Altern. Lab. Anim., 34, 527–538.
Chapin, R., Augustine-Rauch, K., Beyer, B., Daston, G., Finnell, R., Flynn, T., Hunter, S., Mirkes, P., O’Shea, K.S., Piersma, A., Sandler, D., Vanparys, P. and Van Maele-Fabry, G. (2008) State of the art in developmental toxicity screening methods and a way forward: A meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res. B Dev. Reprod. Toxicol., 83, 446–456.
Hong, E.-J. and Jeung, E.-B. (2013) Assessment of developmental toxicants using human embryonic stem cells. Toxicol. Res., 29, 221–227.
Scholz, G., Genschow, E., Pohl, I., Bremer, S., Paparella, M., Raabe, H., Southee, J. and Spielmann, H. (1999) Prevalidation of the embryonic stem cell test (EST) - a new in vitro embryotoxicity test. Toxicol. In Vitro, 13, 675–681.
Braun, A.G. and Dailey, J.P. (1981) Thalidomide metabolite inhibits tumor cell attachment to concanavalin A coated surfaces. Biochem. Biophys. Res. Commun., 98, 1029–1034.
Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S. and Becker, K. (2004) Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim., 32, 209–244.
Paquette, J.A., Kumpf, S.W., Streck, R.D., Thomson, J.J., Chapin, R.E. and Stedman, D.B. (2008) Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Res. B Dev. Reprod. Toxicol., 83, 104–111.
留言 (0)